← Back to Clinical Trials
Recruiting NCT04831580

A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

Trial Parameters

Condition Cervical Cancer
Sponsor GOG Foundation
Study Type INTERVENTIONAL
Phase N/A
Enrollment 840
Sex FEMALE
Min Age 18 Years
Max Age N/A
Start Date 2022-03-22
Completion 2028-08
Interventions
da Vinciopen surgery

Brief Summary

This is a randomized controlled trial to compare survival for patients who undergoe robotic assisted laparoscopy versus open hysterectomy and lymph node assessment for the treatment of early stage cervical cancer.

Eligibility Criteria

Inclusion Criteria: 1. Patient must have histologically confirmed adenocarcinoma (usual/classic/NOS), squamous cell carcinoma, adenosquamous carcinoma (Including glassy cell) 2. Patient must be FIGO Stage IA2, IBI, IB2 (2018 staging) without evidence of definitive parametrial, vaginal, nodal or distant metastases on exam or imaging. Patients with tumor size less than or equal to 4 cm confirmed on MRI prior to randomization are eligible. 3. Patient must have uterine size \<12 cm AND felt to be appropriate for vaginal delivery of the specimen per investigator. 4. Patient must be suitable surgical candidate with preoperative assessments such as labs and EKG performed per institutional standard and agree to be randomized to undergo open or robotic radical (or simple) hysterectomy. NOTE: Simple hysterectomy will be allowed in patients who meet the following criteria: 1. pelvic MRI must demonstrate a maximal tumor size of 2 cm or less AND 2. less than 50% stromal invasion on MRI if tumor pre

Related Trials